Miliband eyes refinery support after Lindsey collapse
Sky News understands that Ed Miliband, the energy security secretary, wants to devise a mechanism for refineries to become eligible for the Energy-Intensive Industries Compensation Scheme - from which they are currently excluded.
Energy costs were at the heart of the government's industrial strategy launched last week.
Such a move would hand a welcome financial boost to the sector by assisting them with energy costs amid a slew of challenges which culminated in the appointment of compulsory liquidators over the Prax Lindsey refinery on Monday.
The site's insolvency - revealed by Sky News - has drawn strong criticism from the government, with energy minister Michael Shanks calling the development "deeply concerning".
"There have been longstanding issues with this company and workers have been badly let down," he said.
"The secretary of state is today writing to the Insolvency Service to demand an immediate investigation into the conduct of the directors, and the circumstances surrounding this insolvency.
"The government will ensure supplies are maintained, protect our energy security, and do everything we can to support workers and the local community, including engaging with trade unions and industry bodies.
"The company has left the government with very little time to act."
Prax Group is owned by Sanjeev Kumar Soosaipillai, who also acts as its chairman and chief executive and is the sole director of the refining subsidiary.
The crisis at the Lindsey refinery, which is located on a 500-acre site five miles from the Humber Estuary, echoes that at Britain's dwindling number of oil refineries.
According to the company, the site has an annual production capacity of 5.4 million tonnes, processing more than 20 different types of crude including petrol, diesel, bitumen, fuel oil and aviation fuels.
The refinery, which was bought from France's Total in 2020, is understood to have become a growing drain on cash across the wider Prax Group, with which it has cross-guarantees.
About 180 people work at State Oil Ltd, Prax Group's parent entity, while roughly 440 more are employed at the Prax Lindsey Refinery.
The rest of the group, which includes oilfield assets in the Shetland Islands and hundreds of UK petrol stations, employs hundreds more people.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
BBC News
17 minutes ago
- BBC News
Brighton go purple for 2025-26 away strip
Brighton have unveiled their away strip for the 2025-26 season - and it is purple!The club say this is the first time they have centralised their crest since Nike took over making the kits in 2014.
The Independent
17 minutes ago
- The Independent
More than a third of homeowners ‘have regrets about their property'
More than a third (37%) of homeowners regret aspects of the home they bought, or would make different decisions if buying again, a survey indicates. Among younger adults, nearly two-thirds (63%) of homeowners aged 34 and under expressed regrets about their property purchase. This compared with just under half (48%) of those aged 35 to 54 and just over a fifth (22%) of homeowners aged 55-plus. Regrets included underestimating the full costs of buying or renovating, dissatisfaction with the location, and having to make compromises on indoor or outdoor space. London homeowners were particularly likely to have regrets about their property purchase, with just over half (51%) saying they would now make different choices. Paula Higgins, chief executive of HomeOwners Alliance, which commissioned the research, said: 'Buying a home is one of the most significant and emotional decisions people make, and our research shows many are left feeling they got it wrong. 'Younger buyers, in particular, are being hit hardest by the realities of the market: high prices, hidden costs, and the pressure to compromise. 'In London, these challenges are even more acute. Sky-high property prices mean buyers are often stretching their budgets to the limit and compromising to get on the ladder.' Ms Higgins added: 'It's worth remembering that even with these regrets, owning a home brings long-term stability and financial security. 'You're building equity, not paying someone else's mortgage, and you have a roof over your head that you can call your own. 'Most homeowners adapt and grow into their homes – they decorate, renovate, build equity, and make the space work for them. 'With time, a house becomes more than a transaction; it becomes a home.' The research was carried out for HomeOwners Alliance in April by Opinium, surveying more than 1,200 homeowners across the UK.
The Independent
17 minutes ago
- The Independent
Fears over £160bn blow to London's stock market as AstraZeneca considers listing move to US
The boss of AstraZeneca, the biggest company on the London Stock Exchange, has discussed shifting the pharmaceutical firm's stock market listing to the US. Such a move would be the biggest hit to the stock market yet, following some huge departures such as £10bn financials firm Wise and £40bn mining business Glencore, among others. The pharmaceutical firm however is far bigger by market capitalisation, currently worth just over £161bn – more than BP, National Grid and Lloyds Bank combined. Pascal Soriot is the chief executive who has held private conversations over moving the listing, first reported the Times, citing frustrations with restrictions around new medicines and pricing structures. The Independent understands the company acknowledges the CEO's concerns as being longstanding, especially regarding new products, while conversations are ongoing with the UK government over support for the wider pharmaceutical industry, particularly when it comes to supporting the commercial environment to become a global superpower in the sector. While the stock market listing would naturally be a huge blow for the UK markets, Mr Soriot could seek to re-domicile the company in the US too. That would bring political pressure too amid a potential huge blow for the government as they both chase economic growth and also get ready to back life sciences as one of the pillars mentioned in the recent industrial strategy. Earlier this year, AstraZeneca ditched plans for a £450m vaccine hub near Liverpool, with 'timing' cited as a reason at the time, while a £12m funding gap was also apparent. While the Conservatives had initially agreed the deal including a £90m pledge, Labour found no record of it after taking power and eventually only committed to £78m. 'Reports that AstraZeneca wants to move its stock listing to the US looks to be driven by business needs rather than chasing a higher valuation,' commented Dan Coatsworth, investment analyst at AJ Bell. 'America is important to its growth strategy and it could become an even bigger cog in the wheel. 'The CEO seems frustrated at the lack of financial support to open new laboratories and manufacturing facilities in Europe and might see a full US stock listing as a stepping stone to receiving better treatment Stateside. 'It won't be an easy move to pull off as unlike many other UK market 'defectors' with a dominant US shareholder base like CRH and Flutter, AstraZeneca has a more geographically diverse pool of investors.' Meanwhile, one key focus of President Trump's tariff plans have been to encourage - or demand - more pharmaceutical companies ply their trade in the US. The EU are trying to arrange in a trade deal for pharmaceuticals to be one of the industries which get a lower than 10 per cent base tariff for exports. A total of 40.4 per cent of AstraZeneca's total $54bn (£39bn) revenue for 2024 came from the US alone: $21.8bn (£159bn), compared to $11.7bn from Europe and $12.6bn from Asia, Africa and Australasia combined. AstraZeneca does already have American depositary receipts trading in the US, which allows investors to locally trade in their shares. At the close of Monday's market, their share price on the LSE had risen more than 2 per cent to above £104, before falling back 0.5 per cent lower in Tuesday morning trading. When contacted, the company did not directly comment on any listing speculation. Board approval would be required to move the shares overseas. Mr Soriot earned £16.85m in 2023 as the highest-paid CEO among any FTSE 100 firm.
